Sanson, Rachel .
HRN: 24-38-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2024
CEFTRIAXONE 1G (VIAL)
01/11/2024
01/17/2024
IV
2g
Q24h
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes